Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Feature

Perspectives
Creating an Enabling Environment for Specialty Alternative Payment Models: A Potential Role for Philanthropy
04/12/2023
Elizabeth Shaughnessy, MA
Lindee Goh, PhD
Joel Ang, DPM, MS
Elizabeth Shaughnessy and colleagues discuss how philanthropic support may be a helpful and overlooked resource to facilitate a better enabling environment for specialty APMs.
Elizabeth Shaughnessy and colleagues discuss how philanthropic support may be a helpful and overlooked resource to facilitate a better enabling environment for specialty APMs.
Elizabeth Shaughnessy and...
04/12/2023
Journal of Clinical Pathways

Advertisement

OCPC: In Session
Patient Perspectives About Cancer Clinical Pathways and Care Coordination
04/11/2023
Deborah E. Collyar
Deborah E. Collyar discusses how patients feel through their cancer experience and suggests ways to incorporate important components like social determinants of health; diversity, equity, and inclusion strategies; and cost considerations so...
Deborah E. Collyar discusses how patients feel through their cancer experience and suggests ways to incorporate important components like social determinants of health; diversity, equity, and inclusion strategies; and cost considerations so...
Deborah E. Collyar discusses how...
04/11/2023
Journal of Clinical Pathways
Research Reports
Belief in Research, Religious Coping, and Willingness to Participate in Clinical Trials Among African American Patients With Hematologic Malignancies: A Pilot Study
02/06/2023
Marjorie E Petty, PhD, MSN
Cynthia Chernecky, PhD, RN, AOCN, FAAN
Irina Shishkina, BSN
Nita Maihle, PhD
Jean Pawl, PhD, RN, OCN, CNE
Jennifer L Waller, PhD
Lufei Young, PhD, RN, APRN-NP
Julie Zadinsky, PhD, MSS, RN, CIP
Petty et al evaluated the belief in research, religious coping, and willingness to participate in clinical trials by African American patients with hematologic malignancies. The basis for their exploration is that, while the AA population has...
Petty et al evaluated the belief in research, religious coping, and willingness to participate in clinical trials by African American patients with hematologic malignancies. The basis for their exploration is that, while the AA population has...
Petty et al evaluated the belief...
02/06/2023
Journal of Clinical Pathways
Research Reports
Post–COVID-19 Syndrome Clinical Pathway for the US Veterans Health Administration
02/06/2023
Claudia L Campos, MD
Cristina Nguyen, BS
Kristina Crothers, MD
Omar Awan, MD
Francis J Miller Jr, MD
Courtney Sedillo, MSN, FNP-C
Johnson Vachachira, NP
Carrie B May, PsyD
Allison M Gustavson, DPT, PhD
Jacob B Lindheimer, PhD
Lindheimer et al summarize the stepwise diagnostic approach for patients presenting with PCS dyspnea and/or cough in primary care and highlight teleconsultation and telerehabilitation as opportunities to reach those in rural areas or with...
Lindheimer et al summarize the stepwise diagnostic approach for patients presenting with PCS dyspnea and/or cough in primary care and highlight teleconsultation and telerehabilitation as opportunities to reach those in rural areas or with...
Lindheimer et al summarize the...
02/06/2023
Journal of Clinical Pathways

Advertisement

Research Reports
Impact of Shared Decision-Making and Patient Decision Aids on Health Care Cost and Utilization in the US: A Systematic Review
12/05/2022
Theresa Schmidt, MA
Tom Valuck, MD, JD
Jacqlyn Riposo, MBA
Palak Patel, MHA
Brittany Perkins, MPH
Kimberly Westrich, MA
Robert W Dubois, MD, PhD
The authors summarize evidence on the impact of shared decision-making as a process, patient decision aids as tools to support decision-making, and the combination of shared decision-making and patient decision aids on cost, utilization, and...
The authors summarize evidence on the impact of shared decision-making as a process, patient decision aids as tools to support decision-making, and the combination of shared decision-making and patient decision aids on cost, utilization, and...
The authors summarize evidence...
12/05/2022
Journal of Clinical Pathways
Research Reports
Measuring Telehealth Quality in Cancer Care: We Don’t Know What We Don’t Know
11/15/2022
David Blaisdell
Tom Valuck, MD, JD
The authors evaluate key quality considerations related to the use of telehealth in oncology in the context of the National Committee for Quality Assurance and the National Quality Forum's recommendations and discuss strategies to enhance...
The authors evaluate key quality considerations related to the use of telehealth in oncology in the context of the National Committee for Quality Assurance and the National Quality Forum's recommendations and discuss strategies to enhance...
The authors evaluate key quality...
11/15/2022
Journal of Clinical Pathways
Research Reports
Optimizing Patient-Provider Communication in Patients With Amyloidosis Using a Virtual Platform
11/15/2022
Arabella Sykes, BSc
Sabrina Rebello, MPH
Isabelle Lousada, MA
Kristen Hsu, BSc
Jason Shore, MBA
Vaishali Sanchorawala, MD
Lisa Mendelson, MSN
Adam Sodowick, BA
The authors present a study that aimed to investigate the real-world use of a virtual platform, Amyloidosis Appointment Companion, in improving communication between patients with amyloidosis and their providers.
The authors present a study that aimed to investigate the real-world use of a virtual platform, Amyloidosis Appointment Companion, in improving communication between patients with amyloidosis and their providers.
The authors present a study that...
11/15/2022
Journal of Clinical Pathways

Advertisement

Research Reports
Improving Biosimilar Adoption Rates and Affordability With Oncology Pathways
08/15/2022
Stephen Hamilton, MD
Kathryn Christensen, MS
Margaret Rausa, PharmD
Nick Andrews, PharmD
Timothy Dollear, MS
Christopher Linkimer, CPA
Eric Gratias, MD, FAAP
Dr Hamilton and colleagues outline how eviCore Healthcare offered the option for payer clients to implement a biosimilar preferencing policy, analyzing how this policy affected the rate of biosimilar use and costs.
Dr Hamilton and colleagues outline how eviCore Healthcare offered the option for payer clients to implement a biosimilar preferencing policy, analyzing how this policy affected the rate of biosimilar use and costs.
Dr Hamilton and colleagues...
08/15/2022
Journal of Clinical Pathways
Research Reports
Phase II: A Value-Based Collaborative Care Model by Payers, Providers, and Pharma
08/11/2022
Lili Brillstein, MPH
Mary Aikins, RN, CCM
Michael Udwin, MD, FACOG
Eric McCulley, RN
A group of stakeholders determined several key challenges to delivering care to patients with psoriatic arthritis, and highlighted several points that should be considered when building a value-based care model for this patient group.
A group of stakeholders determined several key challenges to delivering care to patients with psoriatic arthritis, and highlighted several points that should be considered when building a value-based care model for this patient group.
A group of stakeholders...
08/11/2022
Journal of Clinical Pathways
Research Reports
The Economic Impact of Treatment Sequences for Chronic Lymphocytic Leukemia in the United States: A Cost of Care and Budget Impact Model of Venetoclax Plus Obinutuzumab Sequences
06/21/2022
Matthew S Davids MD, MMSC
Beenish S Manzoor, PhD, MPH
Nisha C Hazra, PhD, MSc
Honghao Fang, MSc
Arliene Ravelo, MPH
Fang Han
Annie Guerin, MS
Kavita Sail, PhD
Sheila Shapouri, MS
Mazyar Shadman, MD, MPH
Dr Davids and colleagues estimated the total cumulative costs per patient of treatment sequences for adults with chronic lymphocytic leukemia, with and without deletion 17p, as well as the budget impact of introducing sequences with...
Dr Davids and colleagues estimated the total cumulative costs per patient of treatment sequences for adults with chronic lymphocytic leukemia, with and without deletion 17p, as well as the budget impact of introducing sequences with...
Dr Davids and colleagues...
06/21/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
Special Report
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
01/14/2021
01/14/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use